Correction of B-scan distortion for optimum ultrasonic imaging of back walls with complex geometries

Ultrasound undergoes refraction and reflection at interfaces between media of different acoustic refractive indices. The most common ultrasonic method (pulse-echo) monitors the reflected energy to infer the presence of flaws, whereas the lower amplitude of refracted signals is ignored. When the reflector is orientated normally with respect to the ultrasonic beam, the received echo signal shows the maximum amplitude. The pulse-echo method also relies on monitoring the amplitude of the backwall echo to identify or confirm the presence of defects. This works well for parts with constant thickness and with planar backwalls. Unfortunately, parts with complex backwalls are common to many industrial sectors. For example, applications such as aerospace structures often require parts with complex shapes. Assessing such parts reliably is not trivial and can cause severe downtime in the aerospace manufacturing processes or during in-service inspections. This work aims to improve the ultrasonic inspectability of parts with complex backwalls, through sending ultrasonic beams from the frontwall side. Ultrasonic phased array probes and state-of-the-art instrumentation allow ultrasonic energy to be sent into a part at wide ranges of focusing depths and steering angles. This allows for tracking of the backwall profile, thus hitting it normally and maximising the amplitude of the reflected echo at any point. However, this work has shown that a cross-sectional scan resulting from multiple ultrasonic beams, which are sent at variable incidence angles, can present significant geometrical distortion and cannot be of much use for accurate defect visualisation and sizing. This paper introduces a generalised algorithm developed to remove geometric distortions and the effect that variable refraction coefficients have on the transmitted and received amplitudes. The algorithm was validated through CIVA simulations for two example parts with complex backwalls, considering isotropic materials

CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke

Aim: Up-regulation of soluble CD40 ligand (sCD40L) and of monocyte chemoattractant protein-1 (MCP-1) has been found in diabetes and in patients with acute cerebral ischemia. We asked whether (i) the two molecules are similarly upregulated among non-lacunar and lacunar diabetic strokes and (ii) sCD40L and/or MCP-1 predict the risk of cardiovascular events in this setting.Methods: Ninety patients with type 2 diabetes mellitus presenting with an acute ischemic stroke (compared with 45 control subjects) were evaluated on admission and up to 36 months (median 24 months) after the event.Results: Diabetic patients with acute stroke had higher plasma CD40L and MCP-1 than controls (p<0.0001), with no significant differences among lacunar and non-lacunar strokes. On multiple regres-sion analysis, only higher sCD40L quartiles and older age were associated with higher MCP-1 quar-tiles. Forty-eight percent of patients experienced vascular events. Cox regression analysis showed that only the presence of higher sCD40L values independently predicted the recurrence of vascular events.Conclusion: Up-regulation of inflammatory molecules, such as CD40L and MCP-1, is involved in the advanced stage of atherosclerotic cerebro-vascular disease and is associated with increased risk of recurrence of cardiovascular events.AIM: Up-regulation of soluble CD40 ligand (sCD40L) and of monocyte chemoattractant protein-1 (MCP-1) has been found in diabetes and in patients with acute cerebral ischemia. We asked whether (i) the two molecules are similarly upregulated among non-lacunar and lacunar diabetic strokes and (ii) sCD40L and/or MCP-1 predict the risk of cardiovascular events in this setting. METHODS: Ninety patients with type 2 diabetes mellitus presenting with an acute ischemic stroke (compared with 45 control subjects) were evaluated on admission and up to 36 months (median 24 months) after the event. RESULTS: Diabetic patients with acute stroke had higher plasma CD40L and MCP-1 than controls (p<0.0001), with no significant differences among lacunar and non-lacunar strokes. On multiple regression analysis, only higher sCD40L quartiles and older age were associated with higher MCP-1 quartiles. Forty-eight percent of patients experienced vascular events. Cox regression analysis showed that only the presence of higher sCD40L values independently predicted the recurrence of vascular events. CONCLUSION: Up-regulation of inflammatory molecules, such as CD40L and MCP-1, is involved in the advanced stage of atherosclerotic cerebro-vascular disease and is associated with increased risk of recurrence of cardiovascular events

Soluble CD40 ligand plasma levels in lung cancer

: Tumor-induced platelet activation may cause the release of various cytokines, including CD40 ligand (CD40L). Activation of the CD40/CD40L pathway in human tumors may result in thrombin generation, which is known to be involved in angiogenesis. Thus, we investigated whether soluble (s)CD40L levels are increased in patients with lung cancer as a result of platelet and/or coagulation activation. EXPERIMENTAL DESIGN: Citrated plasma samples were obtained from 120 patients with different stages and histotypes of lung cancer and 60 age- and sex-matched control subjects. sCD40L, sP-selectin (marker of platelet activation), prothrombin fragment 1 + 2, and thrombin-antithrombin III complex levels (both markers of coagulative activation) were measured in all samples. RESULTS: Patients with lung cancer had median sCD40L levels higher than in control subjects (0.46 versus 0.13 ng/ml; P < 0.0001), although correlation with the stage of disease was not evident. Nonetheless, sCD40L levels were significantly higher in squamous cancer compared with adenocarcinoma (0.75 versus 0.27 ng/ml; P < 0.05). Moreover, median sCD40L levels were higher in stage IV compared with nonmetastatic squamous lung cancer (1.02 versus 0.61 ng/ml; P < 0.05). sCD40L levels significantly correlated with sP-selectin (P < 0.001), prothrombin fragment 1 + 2 (P < 0.001), or thrombin-antithrombin III complex (P < 0.05) in squamous lung cancer, but only sP-selectin (P = 0.011) was independently related to sCD40L. CONCLUSIONS: These findings indicate that elevated sCD40L levels can be preferentially found in patients with advanced squamous cancer and provide evidence that increased levels of this cytokine are associated to the occurrence of in vivo platelet activatio

Disease activity states, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept

The advent of biologic medications has increased considerably the potential for treatment benefit in juvenile idiopathic arthritis (JIA), with clinical remission being now achievable in a substantial proportion of patients. However, there is a need of data from the real world of clinical practice to evaluate thoroughly the efficacy and safety profile of the biologic agents currently approved

Lifespan theorem for constrained surface diffusion flows

We consider closed immersed hypersurfaces in $\R^{3}$ and $\R^4$ evolving by a class of constrained surface diffusion flows. Our result, similar to earlier results for the Willmore flow, gives both a positive lower bound on the time for which a smooth solution exists, and a small upper bound on a power of the total curvature during this time. By phrasing the theorem in terms of the concentration of curvature in the initial surface, our result holds for very general initial data and has applications to further development in asymptotic analysis for these flows.Comment: 29 pages. arXiv admin note: substantial text overlap with arXiv:1201.657

Macrophage activation syndrome (MAS) in juvenile systemic lupus erythematosus (JSLE): an underrecognized complication?

PubMe

Non-Malleable Codes for Decision Trees

We construct efficient, unconditional non-malleable codes that are secure against tampering functions computed by decision trees of depth $d = n^{1/4-o(1)}$. In particular, each bit of the tampered codeword is set arbitrarily after adaptively reading up to $d$ arbitrary locations within the original codeword. Prior to this work, no efficient unconditional non-malleable codes were known for decision trees beyond depth $O(\log^2 n)$. Our result also yields efficient, unconditional non-malleable codes that are $\exp(-n^{\Omega(1)})$-secure against constant-depth circuits of $\exp(n^{\Omega(1)})$-size. Prior work of Chattopadhyay and Li (STOC 2017) and Ball et al. (FOCS 2018) only provide protection against $\exp(O(\log^2n))$-size circuits with $\exp(-O(\log^2n))$-security. We achieve our result through simple non-malleable reductions of decision tree tampering to split-state tampering. As an intermediary, we give a simple and generic reduction of leakage-resilient split-state tampering to split-state tampering with improved parameters. Prior work of Aggarwal et al. (TCC 2015) only provides a reduction to split-state non-malleable codes with decoders that exhibit particular properties